$117.18 +0.70 (%) Celgene Corp - NASDAQ

Dec. 19, 2014 | 04:00 PM

Partner Headlines

  1. Juno Therapeutics IPO Hot As Cancer Curers In Demand

    IBD | Dec. 19, 2014 | 18:32PM EST
  2. #PreMarket Movers From December 19, 2014: NQ Mobile, BlackBerry, CarMax And More

    Benzinga | Dec. 19, 2014 | 09:20AM EST
  3. #PreMarket Primer: Monday, December 15: Hostages Taken In Downtown Sydney

    Benzinga | Dec. 15, 2014 | 07:52AM EST
  4. Meet 5 Top Biotech Stocks Holding Up In Shaky Market

    IBD | Dec. 13, 2014 | 08:02AM EST
  5. IBD 50: Growth Stocks Fight The Fight In Weak Tape

    IBD | Dec. 12, 2014 | 18:11PM EST
  6. United Therapeutics: Will It Pass Peers In 2015?

    IBD | Dec. 12, 2014 | 18:11PM EST
  7. Celgene drug could gain share

    IBD | Dec. 11, 2014 | 19:00PM EST
  8. Gilead Sciences Bucks Trend In Biotech Short Interest

    Benzinga | Dec. 11, 2014 | 12:06PM EST
  9. Celgene's Abraxane Succeeds In Early Breast Cancer

    IBD | Dec. 11, 2014 | 11:27AM EST
  10. How To Invest: Don't Mix CAN SLIM With Other Systems

    IBD | Dec. 10, 2014 | 18:09PM EST
  11. Bluebird Bio Stock Spikes On New Blood Treatment

    IBD | Dec. 9, 2014 | 14:10PM EST
  12. 3 Biotech ETFs Rally On Merger News

    Benzinga | Dec. 8, 2014 | 17:43PM EST
  13. Mid-Afternoon Market Update: Dow Slides Over 100 Points; Oil Futures Down 4%

    Benzinga | Dec. 8, 2014 | 15:37PM EST
  14. Stocks Sink In Late Trading: Tesla, McDonald's Dive

    IBD | Dec. 8, 2014 | 15:06PM EST
  15. Celgene, Acceleron Pharma Report Prelim. Data from Ongoing Phase 2 Trials in Patients with Lower Risk MDS:: Luspatercept, Sotatercept Increased Hemoglobin Levels

    Benzinga | Dec. 8, 2014 | 14:04PM EST
  16. Celgene Offers Results from Phase III Study of REVLIMID, Showed Improved Transfusion Independence

    Benzinga | Dec. 8, 2014 | 13:51PM EST
  17. Stocks Fall To Session Lows: GoPro Gives Up More Ground

    IBD | Dec. 8, 2014 | 13:25PM EST
  18. Mid-Day Market Update: McDonald's Drops On Weak November Sales; Acceleron Pharma Shares Jump

    Benzinga | Dec. 8, 2014 | 12:56PM EST
  19. Stock Market Today: Jazz Hits New High, In Buy Range

    IBD | Dec. 8, 2014 | 12:02PM EST
  20. Mid-Morning Market Update: Markets Mixed; Merck To Buy Cubist Pharmaceuticals For $102/Share

    Benzinga | Dec. 8, 2014 | 10:46AM EST
  21. Stocks Mixed In Early Going; McDonald's Takes Heat

    IBD | Dec. 8, 2014 | 10:28AM EST
  22. Stocks Hitting 52-Week Highs

    Benzinga | Dec. 8, 2014 | 10:08AM EST
  23. Morning Market Movers

    Benzinga | Dec. 8, 2014 | 09:44AM EST
  24. Benzinga's Top #PreMarket Gainers

    Benzinga | Dec. 8, 2014 | 08:11AM EST
  25. Acetylon Begins Phase 2 Study Of Ricolinostat With Pomalyst

    Benzinga | Dec. 4, 2014 | 09:08AM EST
  26. Top Funds Gobble Up Tech And Medical Stocks

    IBD | Dec. 2, 2014 | 18:19PM EST
  27. A Look At 3 Overbought ETFs

    Benzinga | Dec. 2, 2014 | 17:34PM EST
  28. Stock Market Today Opens Higher; FedEx, Biogen, Cypress Surge

    IBD | Dec. 2, 2014 | 11:02AM EST
  29. Meet 5 Top Drug Stocks That Are Bolting Past Market

    IBD | Dec. 2, 2014 | 08:02AM EST
  30. Celgene Recommends Shareholders Reject "Mini-Tender" Offer By TRC Capital Corporation

    Benzinga | Dec. 1, 2014 | 16:32PM EST
  31. IBD 50 Index Still Lags, But Some Stocks Find Mojo

    IBD | Nov. 28, 2014 | 18:45PM EST
  32. Newly Profitable Medivation Riding High On Drug Sales

    IBD | Nov. 28, 2014 | 17:20PM EST
  33. Nasdaq Climbs, But AT&T, Verizon, Drag Dow Down

    IBD | Nov. 24, 2014 | 16:26PM EST
  34. Chip Stocks, Biotechs Lead Another Nasdaq Rally

    IBD | Nov. 24, 2014 | 14:58PM EST
  35. Alibaba Among 5 Top Stocks With Top Profit Margins

    IBD | Nov. 23, 2014 | 08:10AM EST
  36. Pharma drugs advance in EU

    IBD | Nov. 21, 2014 | 18:19PM EST
  37. Healthy Market Critical For A Growth Stock's Success

    IBD | Nov. 21, 2014 | 18:12PM EST
  38. AbbVie, Celgene, Sanofi Drugs Get EU Endorsements

    IBD | Nov. 21, 2014 | 12:28PM EST
  39. Celgene Receives Positive CHMP Opinion For OTEZLA, The First Oral PDE4 Inhibitor For The Treatment Of Patients With Psoriasis And Psoriatic Arthritis

    Benzinga | Nov. 21, 2014 | 06:02AM EST
  40. UPDATE: Bionor Pharma Announces That the Combination of Vacc-4x + Revlimid(R) Is Well Tolerated ...

    GuruFocus | Nov. 18, 2014 | 11:03AM EST
  41. Bionor Pharma Announces That the Combination of Vacc-4x + Revlimid(R) Is Safe and Increases CD4 ...

    GuruFocus | Nov. 17, 2014 | 11:03AM EST
  42. Medical Stocks Tumble But Most Of IBD 50 Trading Well

    IBD | Nov. 14, 2014 | 18:47PM EST
  43. Biotech Stocks Hit: Stock Market To See New Leaders?

    IBD | Nov. 14, 2014 | 18:22PM EST
  44. Stock Market Treads Water; Earnings Drive BitAuto

    IBD | Nov. 14, 2014 | 16:21PM EST
  45. Stocks Drift Lower As Biotechs Tumble

    IBD | Nov. 14, 2014 | 14:48PM EST
  46. Stocks Mixed; Amazon Jumps On Book Deal

    IBD | Nov. 14, 2014 | 13:32PM EST
  47. Stocks Flat While Medical Issues Tumble

    IBD | Nov. 14, 2014 | 12:04PM EST
  48. Which Mega Caps Are Buying Their Own Stock?

    Benzinga | Nov. 13, 2014 | 15:51PM EST
  49. Celgene Is Up 22% Over The Past Month; What Do Technicians Think?

    Benzinga | Nov. 13, 2014 | 14:12PM EST
  50. Big Cap 20 Stuffed With Medical Names

    IBD | Nov. 10, 2014 | 19:34PM EST
Trading Center